About octocog alfa
Recombinant coagulation factor VIII
Used for
- Prevention and treatment of bleeding in haemophilia A
- Bleeding control during and after surgery in haemophilia A
Usual adult dose
Individualised by bleed severity, target factor level, and body weight; commonly 20–50 IU/kg per dose.
Usual dose in children
Individualised by bleed severity, target factor level, and body weight; commonly 20–50 IU/kg per dose.
Common side effects
- Headache
- Fever
- Joint pain
- Development of factor VIII inhibitors
Important warnings
- Allergic reactions, including severe reactions, can occur.
- Factor VIII inhibitors may reduce treatment effectiveness.
- Seek urgent care for signs of a serious allergic reaction.
- Dose and monitoring require specialist haemophilia care.
Pregnancy
Limited human data; use when clearly needed, under specialist supervision.
Breastfeeding
Limited information; use when needed after considering benefits and risks.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.